POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION

Published:1999-11 Issue:9 Volume:68 Page:1288-1294
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Kovarik John M.,Kahan Barry D.,Rajagopalan P. R.,Bennett William,Mulloy Laura L.,Gerbeau Christophe,Hall Michael L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference12 articles.

1. Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts

2. PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATION

3. Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

4. DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1

5. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction Therapy;Transplantation of the Pancreas;2023

2. Basiliximab as maintenance immunosuppression in heart transplant recipients: A single pediatric center experience;Pediatric Transplantation;2022-11-17

3. Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target‐mediated drug disposition model;British Journal of Clinical Pharmacology;2022-02

4. Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation;Drug Discovery Today;2021-11

5. Implications for body weight extremes in solid organ transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3